Electrical Stimulation + Vitamin D for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to improve bone health in Veterans with spinal cord injuries. Researchers are testing whether combining electrical muscle stimulation (which uses electrical impulses to contract muscles) with Vitamin D can strengthen bones and reduce fracture risk. Participants will be divided into two groups: one will perform muscle training exercises with electrical stimulation and take Vitamin D, while the other will engage in passive movement exercises with Vitamin D. The trial seeks Veterans who primarily use a wheelchair and have a traumatic spinal cord injury. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group of people.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on anti-coagulation or anti-platelet therapy, including aspirin.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that neuromuscular electrical stimulation (NMES) is generally safe, with thousands of sessions recorded without major problems. It has been used effectively in treating spinal cord injuries. Previous studies support combining NMES with vitamin D, showing it is well-tolerated.
For the passive movement plus vitamin D approach, studies suggest that vitamin D is safe and important for health after a spinal cord injury, aiding muscle health and other body functions. Passive movement exercises improve heart and muscle health without causing harm.
Past studies have shown these treatments to be well-tolerated, providing reassurance of their safety.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for spinal cord injury because they combine innovative approaches that differ from traditional methods like surgery or medication. The first treatment arm uses Neuromuscular Electrical Stimulation (NMES) alongside Vitamin D, which aims to enhance muscle strength and nerve function through electrical impulses, while the added Vitamin D may support bone health and immune function. The second treatment arm pairs passive movement exercises with Vitamin D, which could offer a gentler, home-based rehabilitation strategy that still supports overall recovery. These approaches not only introduce new mechanisms—like electrical stimulation and passive movement—but also focus on integrating daily Vitamin D supplementation to potentially boost the effectiveness of physical rehabilitation.
What evidence suggests that this trial's treatments could be effective for spinal cord injury?
Research has shown that Neuromuscular Electrical Stimulation (NMES) combined with Vitamin D, which participants in this trial may receive, might improve bone health for individuals with spinal cord injuries. Studies indicate that NMES can slow bone loss in the legs, crucial because spinal cord injuries often weaken bones. Vitamin D strengthens bones and aids recovery by enhancing muscle function.
Another group in this trial will receive passive movement and Vitamin D. This approach involves Vitamin D supplements, which may correct low Vitamin D levels common in individuals with spinal cord injuries and can slow recovery. Passive movement might boost blood flow, potentially supporting bone health. Together, these treatments aim to address bone issues related to spinal cord injuries in different ways.14678Who Is on the Research Team?
Dora E Ifon, PhD
Principal Investigator
Hunter Holmes McGuire VA Medical Center, Richmond, VA
Are You a Good Fit for This Trial?
This trial is for Veterans aged 18-65 with a history of traumatic spinal cord injury (SCI) at least one year prior, specifically with injuries between C8-T10 and classified as AIS A or B. Participants must be wheelchair users, have responsive knee extensors to electrical stimulation, a caregiver to assist, and clearance from their medical provider. Excluded are those over 65, with severe osteoporosis or other major health issues like uncontrolled diabetes or cardiovascular disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 4.5 months of open kinematic chain resistance training followed by 4.5 months of closed kinematic chain using a simple rowing approach, with daily 2000IU oral vitamin D supplementation
Follow-up
Participants are monitored for changes in trabecular microarchitecture, bone biomarkers, muscle area, bone mineral density, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- NMES
- Passive movement
- Vitamin D
NMES is already approved in United States, European Union for the following indications:
- Muscle wasting and weakness after subarachnoid hemorrhage (SAH)
- Rehabilitation post-SAH
- Muscle weakness and wasting in critically ill patients
- Rehabilitation post-SAH
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
NYU Langone Health
Collaborator
Virginia Commonwealth University
Collaborator